Sleep disruption has been implicated in morbidity after major surgery since 1974. Sleep-related upper airway obstruction has been associated with death after upper airway surgery and profound episodic hypoxaemia in the early postoperative period. There is also evidence for a rebound in rapid eye movement (REM) sleep that might be contributing to an increase in episodic sleep-related hypoxaemic events later in the first postoperative week. Speculation regarding the role of REM sleep rebound in the generation of late postoperative morbidity and mortality has evolved into dogma without any direct evidence to support it. The research presented in this thesis involved two main areas: a search for evidence of a clinically important contribution of REM sleep rebound to postoperative morbidity, and a re-examination of the role of sleep in the causation of postoperative episodic hypoxaemic events. To assess the latter, a relationship between airway obstruction under anaesthesia and the severity of sleep-disordered breathing was sought. In 148 consecutive sleep clinic patients, 49% of those with sleep-disordered breathing (SDB) had a number of events in non-rapid eye movement sleep (NREM) that was greater than or equal to that in REM and 51% had saturation nadirs in NREM that were equal to or worse than their nadirs in REM. This suggests SDB is not a REM-predominant phenomenon for most patients. Of 1338 postoperative deaths occurring over 6.5 years in one hospital only 37 were unexpected, most of which were one or two days after surgery with no circadian variation in the time of death, casting further doubt on the potential role of REM rebound. Five of nine subjects studied preoperatively had moderately severe SDB. Unrecognised and significant SDB is common in middle-aged and elderly patients presenting for surgery suggesting overall perioperative risk of important adverse events from SDB is probably small. In 17 postoperative patients, sleep macro-architecture was variably altered with decreases in REM and slow wave sleep while stage 1 sleep and a state of pre-sleep onset drowsiness, both associated with marked ventilatory instability, were increased. Sleep micro-architecture was also changed with an increase in power in the alpha-beta electroencephalogram range. These micro-architectural changes result in ambiguity in the staging of postoperative sleep that may have affected the findings of this and other studies. Twenty-four subjects with airway management difficulty under anaesthesia were all found to have some degree of SDB. Those with the most obstruction-prone airways while anaesthetised had a very high incidence of severe SDB. Such patients warrant referral to a sleep clinic.

Diss. (sammanfattning) Göteborg : Göteborgs universitet, 2007. / Härtill 4 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 5 uppsatser.

Thesis (Ph.D.)--University of Melbourne, Dept. of Medicine, Western Hospital, 2007. / Typescript. Includes bibliographical references (leaves 145-181).

Thesis (Ph. D.)--University of Sydney, 2003. / Includes tables and questionnaires. Title from title screen (viewed Apr. 29, 2008). Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy to the Faculty of Medicine. Degree awarded 2003; thesis submitted 2002. Includes bibliography. Also available in print form.

Στην διπλωματική εργασία αυτή παρουσιάζεται ένα μικρό σύστημα εντατικής παρακολούθησης. Παρουσιάζεται πλήρως η κατασκευή ενός οξύμετρου παλμού από πλευράς hardware και software αφού αυτό είναι συνδεδεμένο σε έναν κεντρικό υπολογιστή. Στο τέλος πήραμε μερικά δείγματα από άτομα εθελοντές για να δείξουμε πως λειτουργεί αυτό που έχει κατασκευαστεί. Επίσης παρουσιάζεται μια καινοτόμος ιδέα για την αντιμετώπιση του προβλήματος της υπνικής άπνοιας, που αφορά όχι τόσο πολύ στο θέμα πρόληψη, αλλά στην αντιμετώπιση δύσκολων, ακραίων καταστάσεων. / The current thesis presents a patient’s monitoring system for emergency rooms. It fully presents the construction of a pulse oximeter, including software and hardware development, which is connected to a server computer. Finally, some samples were taken from various volunteers to show how the pulse oximeter works. Also, the thesis presents an innovative idea for the problem of sleep apnea, for dealing critical situations.

Orientador: Silke Anna Teresa Weber / Coorientador: Sérgio Henrique Kieme Trindade / Banca: Letícia Cláudia de Oliveira Antunes / Banca: Kátia Cristina Carmello Guimarães / Resumo: Introdução: A Síndrome da Apnéia Obstrutiva do Sono (SAOS) caracteriza-se pelo colabamento parcial ou completo da faringe, intermitente, que se repete durante todas as fases do sono, fazendo com que o fluxo respiratório seja interrompido durante o evento. A manifestação diurna mais comum de SAOS é a sonolência diurna. A obesidade é o fator causal reversível mais frequente associado a SAOS, sendo a atividade física um importante componente para o seu tratamento. A hipótese levantada para este estudo considerou que pacientes com SAOS apresentariam alterações na sua qualidade do sono, maior sonolência diurna e menor disposição de realização de atividade física, repercutindo em alterações ou até mesmo na redução da capacidade funcional. A utilização adequada do CPAP com pressão terapêutica poderia melhorar essas alterações, mesmo em curto prazo. Objetivo: Avaliar a qualidade do sono, sonolência diurna, disposição para atividade física e a capacidade funcional, antes e após 1 semana do uso de CPAP, calibrado com a pressão terapêutica ou de CPAP calibrado com pressão mínima de 4 cmH2O. Método: Trata-se de um estudo randomizado, duplo cego, com aprovação do comitê de Ética em Pesquisa local (protocolo nº 41/2013). Foram convidados pacientes de ambos os gêneros em acompanhamento no ambulatório de ventilação não invasiva com idade entre 30 a 75 anos, com diagnóstico polissonográfico de SAOS. Os pacientes foram randomizados por sorteio pelo orientador sem conhecimento do fisioterapeuta e foram alocados em dois grupos, sendo o grupo I composto por pacientes em uso de CPAP em pressão mínima de 4 cmH2O e o grupo II por pacientes em uso de CPAP na pressão terapêutica ideal. Todos os pacientes receberam o equipamento de CPAP disponibilizado pelo serviço de ventilação domiciliar com o visor vedado para que o paciente e o fisioterapeuta não tivessem acesso aos dados da calibração. Foram avaliados... / Abstract: Introduction: The Obstructive Sleep Apnea Syndrome (OSAS) characterized by complete or partial collapse of pharynx, intermittently, that is repeated during all the phases of sleep, causing the interruption of respiratory flow during the event. The most common daytime manifestation of OSAS is the daytime sleepiness. Obesity is the reversible casual factor most frequently associated with OSAS, considering physical activity an important component for its treatment. The hypothesis to this study considered that patients with OSAS would present changes in their sleep quality, increased daytime sleepiness and less willingness to perform physical activity, resulting in changes or even on reduced functional capacity. The proper use of CPAP with therapeutic pressure may improve such changes, even in short time. Objective: To assess the sleep quality, daytime sleepiness, willingness for physical activity and the functional capacity before and after 1 week using CPAP, calibrated with therapeutic pressure or CPAP calibrated with minimum pressure of 4 cmH2O. Method: It's about a double-blind and randomized study with approval of the local Ethics Committee in Research (protocol nº 41/2013). It was invited patients of both genders in ambulatory follow-up of non-invasive aged between 30 and 75, with polysomnography diagnosis of OSAS. The patients were selected randomly by the adviser without physiotherapist's awareness and allocated in two groups, whereby the group I is consisted by patients who are using CPAP in minimum pressure of 4 cmH2O and the group II by patients using CPAP in the ideal therapeutic pressure. All patients received the CPAP equipment provided by home ventilation service with sealed display so that the patient and the physiotherapist didn't have access the calibration data. The level of physical activity was assessed by IPAQ questionnaire, daytime sleepiness by Epworth sleepiness scale, sleep quality by Pittsburgh questionnaire and ... / Mestre

Introdução: O desenvolvimento de hipertensão arterial e doença cardiovascular relacionado à síndrome das apnéia obstrutiva do sono (SAOS) parece estar relacionado a alterações sobre a regulação autonômica cardiovascular. Este estudo investigou se a SAOS influência a variabilidade da pressão arterial (PA). Métodos: Estudo transversal, com pacientes hipertensos que foram submetidos à polissonografia nível III, por meio de um monitor portátil de uso domiciliar para detectar SAOS (índice de apnéia-hipopnéia (IAH) ≥ 10). A variabilidade da PA foi avaliada pela taxa de variação da pressão arterial no tempo (índice “time rate” - a primeira derivada da pressão arterial ao longo do tempo) e desvio padrão (DP) da PA obtidos dos dados da monitorização ambulatorial da pressão arterial (MAPA). Análises univariadas e multivariadas foram utilizadas para testar a associação entre a SAOS, IAH e variabilidade da pressão arterial. Resultados: Os pacientes com SAOS (n = 57) eram mais velhos, apresentavam pressão arterial mais elevada e maior duração da hipertensão do que pacientes sem SAOS (n = 50). Não houve nenhuma associação consistente entre o diagnóstico de SAOS e variabilidade da PA aferida pelo DP e pela taxa de variação da PA no tempo, tanto na análise univariada como após o ajuste para idade, IMC e respectiva medida de PA na MAPA. Não houve correlação significativa entre o AIH e os índices de variabilidade da PA em um modelo de regressão linear múltipla, controlando para idade, IMC e PA correspondente. Conclusão: SAOS não influencou a variabilidade da pressão arterial, aferida por estes métodos, em pacientes com hipertensão. / Background The risk of obstructive sleep apnea syndrome (OSAS) for the development of hypertension and cardiovascular disease may be intermediate by influence over autonomic cardiovascular regulation. This study investigated if OSAS influences blood pressure (BP) variability. Methods In a cross-sectional study, patients with hypertension underwent level III polysomnography by means of a home portable monitor to detect OSAS, (apnea-hypopnea index (AHI) ≥10). BP variability was assessed by the time rate index (the first derivative of BP over time) and standard deviation (SD) of BP measured by 24-h ambulatory blood pressure measurement (ABPM). The association between OSAS, AHI and blood pressure variability was tested by univariate and multivariate methods. Results: Patients with OSAS (n = 57) were older, had higher blood pressure, and longer duration of hypertension than patients without OSAS (n = 50). There was no consistent association between the diagnosis of OSAS and BP variability assessed by the time-rate index and SD both in the univariate and after adjustment for age, BMI and the respective BP. There was no significant correlation between AIH and the indexes of BP variability in a multiple linear regression model controlling for age, BMI and the corresponding BP. Conclusion OSAS does not influence blood pressure variability in patients with hypertension.

Resumo: A síndrome da apnéia e hipopnéia obstrutiva do sono (SAHOS) caracteriza-se pela obstrução completa ou parcial das vias aéreas superiores durante o sono sendo comum em indivíduos portadores de Síndrome de Down (SD). O objetivo neste estudo é comparar, por meio da análise em radiografias cefalométricas, em norma lateral, características anatômicas craniofaciais associadas às vias aéreas superiores entre indivíduos portadores de SD, indivíduos portadores de SAHOS e indivíduos não sindrômicos e sem alterações craniofaciais. Além disso, verificar a existência de dimorfismo sexual em relação a essas características nos grupos estudados. Foram realizadas análises computadorizadas em 43 radiografias cefalométricas laterais de indivíduos portadores de SD com idades entre 18 e 34 anos, 26 de indivíduos portadores da SAHOS com idades entre 20 e 70 anos e 29 radiografias cefalométricas de indivíduos não portadores de SD e sem características clínicas de SAHOS com idades entre 18 e 35 anos. Foram avaliadas 14 medidas lineares por meio do software Radiocef Studio 2. Os dados obtidos foram comparados e submetidos à análise de variância (ANOVA) e teste post-hoc de Tukey. Concluimos que existem alterações craniofaciais significantes entre indivíduos portadores de SAHOS e indivíduos não sindrômicos tais como: menor comprimento maxilar e mandibular, naso, oro e hipofaringe com dimensões reduzidas, maior comprimento do palato mole, espaço retropalatal estreitado e osso hióide posicionado mais inferior e anteriormentemente. Dentre as alterações relacionadas à SAHOS, foram encontrados nos indivíduos portadores de SD, menor comprimento da base do crânio, menor comprimento maxilar e mandibular, naso e hipofaringe reduzidas, palato mole aumentado, espaço retropalatal reduzido e osso hióide posicionado mais inferior e anteriormentemente... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Obstructive sleep apnea syndrome is characterized by complete or partial obstruction of the upper airway during sleep, being common in individuals with Down syndrome. The aim of this study is to compare, through analysis of cephalometric radiographs in lateral norm, craniofacial morphology associated with upper airway between individuals with Down syndrome, individuals with obstructive sleep apnea syndrome and non syndromic individuals. Moreover, verify if there is sexual dimorphism in relation to changes in these groups. Computer analysis were performed in 43 lateral cephalometric radiographs of individuals with Down syndrome aged between 18 and 34 years, 26 patients of obstructive sleep apnea syndrome with ages between 20 and 70 years and 29 cephalometric radiographs of non syndromic individuals aged 18 and 35 years old. The analyses were performed using the software Radiocef Studio 2. The data were compared and submitted to analysis of variance (ANOVA) and post-hoc test of Tukey. It was concluded that there are significant craniofacial changes between individuals with and without obstructive sleep apnea syndrome on the lower maxillar and mandibular length, naso, oro and hypopharynx with reduced dimensions, increased length of the soft palate, post-palatal region closer, inferiorly and anteriorly positioned hyoid bone. Among the changes related to obstructive sleep apnea syndrome, that were found in individuals with Down syndrome, the lower length of the base of the skull, lower jaw and mandibular length, reduced nasal and hypo pharynx, longer soft palate, post-palatal region reduced and inferiorly and anteriorly positioned hyoid bone. There is also sexual dimorphism in some factors analyzed: larger anterior skull base, greater length of the maxilla and mandible were found in males in all groups. / Orientador: Luiz Cesar de Moraes / Coorientador: João Carlos da Rocha / Banca: Jefferson Luis Oshiro Tanaka / Banca: Edmundo Medici Filho / Mestre

L'apnée du sommeil (AS) induit des variations constantes d'oxygénation artérielle (hypoxie intermittente – HI) qui affectent environ 5 à 7 % de la population. Il se produit une augmentation du stress oxydatif (production d'espèces réactives de l'oxygène - ROS), augmentant les risques cardiovasculaires, neurologiques et métaboliques. Les études épidémiologiques démontrent que la prévalence d'AS est inférieure chez les femmes que chez les hommes, mais après la ménopause la prévalence augmente pour atteindre le même niveau que chez les hommes. L'oestradiol (E2) est un puissant agent antioxydant, mais son rôle éventuel dans le traitement ou la prévention de l'AS n'est pas exploité. Toutefois, l'oestradiol (associé ou non à la progestérone) permet de réduire l'AS chez les femmes ménopausées. Les ROS peuvent être produites par les mitochondries, la NADPH oxydase et/ou la Xanthine oxydase. La mitochondrie est le plus important producteur de ROS (90% de l'oxygène consommé) et son dysfonctionnement est très préjudiciable. L'oestradiol est une cible de la mitochondrie à travers ses récepteurs nucléaires alpha et bêta (ERα et ERβ) qui sont capables de moduler le fonctionnement de la mitochondrie et diminuer la production de ROS. Nous avons testé l'hypothèse dans un modèle animal ovariectomisé exposé à une HI, que l'estradiol et ses agonistes spécifiques ERα et Erβ sont capables de limiter le stress oxydatif cérébral, la dysfonction mitochondriale et l'apparition des désordres systémiques. Nos résultats ont permis de montrer que l'estradiol est capable d'éviter l'augmentation de la pression artérielle et la survenue de désordres respiratoires causés par l'HI. De plus, l'HI augmente le stress oxydatif cérébral en augmentant l'activité d'enzymes pro-oxydantes et en diminuant l'activité d'enzymes antioxydantes. L'estradiol permet de prévenir l'augmentation du stress oxydatif. On retrouve également une dysfonction de la chaine respiratoire mitochondriale dans le cortex en HI qui est préservée de manière différente par le traitement avec les modulateurs sélectifs des récepteurs ERα et ERβ (SERMs). Nous avons montré que ERβ joue un rôle dans le contrôle cardio-respiratoire et la fonction mitochondriale dans le cerveau. Nos résultats apportent une meilleure compréhension du rôle de l'estradiol comme agent protecteur contre l'apnée du sommeil et ses conséquences associées. L'utilisation d'agonistes spécifiques nous renseigne sur le rôle que tient chaque récepteur dans la protection induite par l'estradiol contre la dysfonction mitochondriale. L'utilisation du remplacement hormonal avec de l'estradiol ou des SERMs peut constituer une thérapie efficace contre l'apnée du sommeil et ses conséquences / Sleep apnea (SA) induces constant changes of arterial oxygenation (Intermittent hypoxia - IH) that affect about 5 to 7% of the general population. IH increases oxidative stress (production of reactive oxygen species – ROS) and lead to cardiovascular, neurological and metabolic risks. Epidemiological studies show that the prevalence of SA is lower in women than in men, but after menopause the prevalence increases to the same level that in men. Estradiol (E2) is a potent antioxidant, but its potential role in the treatment or prevention of SA is not exploited. However, estradiol (with or without progesterone) can reduce SA in postmenopausal women. ROS can be produced by mitochondria, NADPH oxidase and/or Xanthine oxidase. Mitochondria is the most important producer of ROS (90% of oxygen consumed) and its dysfunction is very detrimental. Estradiol is a target of mitochondria through its mitochondria alpha and beta (ERα et ERβ) that are able to modulate mitochondrial function and decrease ROS production. We tested the hypothesis in ovariectomized animal model exposed to IH, that estradiol and its specific receptor ERα and ERβ agonists are able to limit cerebral oxidative stress, mitochondrial dysfunction and the appearance of systemic disorders. Our results have shown that estradiol is able to avoid the increase of blood pressure and the occurrence of respiratory disorders caused by IH. Furthermore, IH increases cerebral oxidative stress by increasing activity of pro-oxidant enzymes and decreasing activity of antioxidant enzymes. Estradiol prevents against the increase of oxidative stress. There is also a mitochondrial respiratory chain dysfunction in the cortex by IH, that is preserved differently by treatment with selective ERα and ERβ receptor modulators (SERMs). We have shown that ERβ plays an important role in cardiorespiratory control and mitochondrial function in the brain. Our results provide a better understanding of the role of estradiol as a protective agent against sleep apnea and its associated consequences. The use of specific agonists informs us on the role of each receptors in estradiol-induced protection against mitochondrial dysfunction. The use of hormone replacement with estradiol or SERMs may be an effective therapy against sleep apnea and its consequences